Editorial
Published on 10 Apr 2024
Editorial: Antibody-mediated rejection
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2024.1408225
- 112 views
Type at least 3 characters
18 articles
Articles
Review
Published on 24 Jan 2024
BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2024.1309927
- 373 views
Brief Research Report
Published on 11 Jan 2024
Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1280993
- 326 views
Review
Published on 08 Dec 2023
Innate immune modulation in transplantation: mechanisms, challenges, and opportunities
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1277669
- 331 views
Clinical Trial
Published on 21 Nov 2023
Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1273890
- 353 views
Original Research
Published on 09 Nov 2023
Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1233322
- 296 views
Review
Published on 09 Nov 2023
The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1237671
- 250 views
Original Research
Published on 30 Oct 2023
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1284740
- 743 views
Original Research
Published on 16 Oct 2023
Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1279940
- 417 views
Review
Published on 29 Sep 2023
Management of donor-specific antibodies in lung transplantation
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1248284
- 603 views
Original Research
Published on 04 Sep 2023
Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1248987
- 603 views
Original Research
Published on 01 Sep 2023
Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1230393
- 499 views
Review
Published on 21 Aug 2023
Tacrolimus—why pharmacokinetics matter in the clinic
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1160752
- 1,797 views
Review
Published on 28 Apr 2023
New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1146040
- 979 views
Original Research
Published on 20 Apr 2023
Combination of everolimus and low-dose tacrolimus controls histological liver allograft injury as sufficiently as high-dose tacrolimus
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1168163
- 949 views
Perspective
Published on 19 Apr 2023
Translation of therapeutic strategies to modulate B cell reponses from non-human primate models to human kidney transplantation
in Immunosuppression
Frontiers in Transplantation
doi 10.3389/frtra.2023.1176796
- 455 views